Skip to main content

ADVERTISEMENT

head and neck cancer

News
03/07/2016
SACRAMENTO, California, March 4, 2016 /PRNewswire/ --New radiosurgery system enables unprecedented precision in the frameless treatment of brain tumors Elekta, a leading supplier of advanced and innovative radiation...
SACRAMENTO, California, March 4, 2016 /PRNewswire/ --New radiosurgery system enables unprecedented precision in the frameless treatment of brain tumors Elekta, a leading supplier of advanced and innovative radiation...
SACRAMENTO,...
03/07/2016
IO Learning
News
04/07/2015
 CHOP Scientists Explore Ultrasmall Drug Delivery Vehicles to Target Neuroblastoma, a Pediatric CancerNewswise — Philadelphia, April 2, 2015 – Delving into the world of the extremely small, researchers are exploring how...
 CHOP Scientists Explore Ultrasmall Drug Delivery Vehicles to Target Neuroblastoma, a Pediatric CancerNewswise — Philadelphia, April 2, 2015 – Delving into the world of the extremely small, researchers are exploring how...
 CHOP Scientists Explore...
04/07/2015
IO Learning
News
03/03/2015
PITTSBURGH, March 2, 2015 – UPMC CancerCenter last week became the first center in the world to treat a patient with the CyberKnife M6 System’s new multileaf collimator, which enables precise shaping of radiation beams to any irregularly...
PITTSBURGH, March 2, 2015 – UPMC CancerCenter last week became the first center in the world to treat a patient with the CyberKnife M6 System’s new multileaf collimator, which enables precise shaping of radiation beams to any irregularly...
PITTSBURGH, March 2, 2015...
03/03/2015
IO Learning
News
01/28/2014
Preclinical Studies Initiated at Brigham and Women's Hospital, Harvard Medical School LAWRENCEVILLE, N.J., Jan. 21, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, announced today that the...
Preclinical Studies Initiated at Brigham and Women's Hospital, Harvard Medical School LAWRENCEVILLE, N.J., Jan. 21, 2014 /PRNewswire/ -- Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, announced today that the...
Preclinical Studies Initiated at...
01/28/2014
IO Learning